Navigation Links
Curcumin may inhibit nicotine-induced activation of head and neck cancers
Date:10/4/2009

San Diego, CA Curcumin, the compound that gives curry powder its yellow/orange color, may inhibit the adverse effects of nicotine in patients with head and neck cancer who continue to smoke.

In a paper presented at the 2009 American Academy of Otolaryngology Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers examined the effects of curcumin on head and neck squamous cell carcinoma (HNSCC) growths. The study used an in vitro model of a variety of head and neck cancer cell lines. To mimic the clinical situation, HNSCC cells were pre-treated with curcumin and then nicotine was introduced. The results of the studies showed that the curcumin was able to block the nicotine from activating cancer causing cells.

Annually there are approximately 40,000 new cases of head and neck cancers and 13,000 deaths in the U.S. and 500,000 new cases worldwide. Recurrence of these cancers are high because many patients continue to smoke after successful treatment. Also, former smokers often use nicotine replacement therapy as an aid for successful tobacco cessation.

Although nicotine itself has not been shown to be carcinogenic, it has been shown to encourage the cancer-forming process. The researchers sought a safe, bioactive food compound that could be used not only as a chemopreventive agent but could also block the harmful effects of nicotine.

The results may help to discover additional therapies for cancer prevention and treatment.


'/>"/>

Contact: Jessica Mikulski
newsroom@entnet.org
703-535-3762
American Academy of Otolaryngology -- Head and Neck Surgery
Source:Eurekalert

Page: 1

Related medicine news :

1. HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimers Disease
2. Inhibition of NF-kappa B, a key inflammatory protein, reduced radiation toxicity in zebrafish
3. Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs
4. Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University
5. HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
6. Surveyed Physicians Will Treat Over 50 Percent of Hepatitis C Genotype 1-Infected Patients With the Protease Inhibitor Telaprevir
7. HIV integrase inhibitor effective for patients beginning antiretroviral treatment
8. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
9. Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production
10. For Treatment of Type 2 Diabetes, 89 Percent of Surveyed Endocrinologists Identify a Need for Additional GLP-1 Analogues and 71 Percent Say the Same About DPP-IV Inhibitors
11. Pharmasset Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Petersburg, FL (PRWEB) , ... April 29, 2016 , ... ... look at products on the market. They recently reviewed the ZEN BOX , ... Typically there are two single essential oils (like lavender or frankincense) and one Zen ...
(Date:4/28/2016)... ... April 28, 2016 , ... Sanford Health’s work in ... group of researchers and leaders from Sanford Health were selected to participate in ... Cultural Impact ” and receive the 2016 Pontifical Key Innovation Award at the ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... is proud to partner with AquaShieldUSA, the country's oldest waterproof cast protector ... and medical supply stores, the largest selection of daily, night, weatherproof and waterproof ...
(Date:4/28/2016)... Austin, TX (PRWEB) , ... ... ... Data Interchange Standards Consortium (CDISC) announces today the open availability of a ... official platforms and catalogs for registering clinical trials. This innovative standard will ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... the Campaign for Tobacco-Free Kids, a leading force in the fight to reduce ... state and local policies that can help reduce tobacco use. The initiative brings ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... TOKYO , April 28, 2016 /PRNewswire/ ... Ahuja , George Phillips und ... wachsenden Unternehmens    ArisGlobal®, ein ... Life Sciences, gab heute bekannt, dass neue ... wachsenden Unternehmens gestoßen sind, die vielfältige Erfahrungen ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life sciences, ... team to bring a wealth of insight to a growing business. ... knowledge. George Phillips joined ArisGlobal in the ...
Breaking Medicine Technology: